Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite

Drug Development and Industrial Pharmacy

Volumn 41, Issue 10, 2015, Pages 1640-1646

  Hamishehkar, Hamed ^a   Shokri, Javad ^b   Fallahi, Shahoo ^c   Jahangiri, Azin ^b   Ghanbarzadeh, Saeed ^b   Kouhsoltani, Maryam ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cellulite; Skin permeation; SLN; Solid lipid nanoparticle; Topical delivery

Indexed keywords

BENZETHONIUM CHLORIDE; CAFFEINE; CARBOMER; GLYCEROL PALMITOSTEARATE; POLOXAMER; POLYSORBATE 20; POTASSIUM DIHYDROGEN PHOSPHATE; SOLID LIPID NANOPARTICLE; ACRYLIC ACID DERIVATIVE; DELAYED RELEASE FORMULATION; DIACYLGLYCEROL; DRUG CARRIER; HYDROGEL; NANOPARTICLE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BUTTOCK; CELLULITE; CONTROLLED STUDY; CYTOLYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG FORMULATION; DRUG STABILITY; FEMALE; HISTOPATHOLOGY; HYDROGEL; IN VITRO STUDY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; RAT; SKIN DISEASE; SKIN PERMEABILITY; STORAGE TEMPERATURE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; THIGH; X RAY POWDER DIFFRACTION; ADIPOSE TISSUE; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRADERMAL DRUG ADMINISTRATION; PHARMACEUTICS; SKIN ABSORPTION; WISTAR RAT; X RAY DIFFRACTION;

ACRYLATES; ADIPOSE TISSUE; ADMINISTRATION, CUTANEOUS; ANIMALS; CAFFEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DIGLYCERIDES; DRUG CARRIERS; DRUG LIBERATION; FEMALE; HYDROGELS; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 84946725788     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.980426     Document Type: Article

References (36)

1. Piérard GE, Nizet J-L, Piérard-Franchimont C. Cellulite: from standing fat herniation to hypodermal stretch marks. Am J Dermatopathol 2000;22:34-7.
2. Rosenbaum M, Prieto V, Hellmer J, et al. An exploratory investigation of the morphology and biochemistry of cellulite. Plast Reconstr Surg 1998;101:1934-9.
3. Lotti T, Ghersetich I, Grappone C, et al. Proteoglycans in so-called cellulite. Int J Dermatol 1990;29:272-4.
4. Rossi ABR, Vergnanini AL. Cellulite: a review. J Eur Acad Dermatol Venereol 2000;14:251-62.
5. Avram MM. Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther 2004;6:181-5.
6. Nürnberger F, Müller G. So-called cellulite: an invented disease. J Dermatol Surg Onc 1978;4:221-9.
7. Roure R, Oddos T, Rossi A, et al. Evaluation of the efficacy of a topical cosmetic slimming product combining tetrahydroxypropyl ethylenediamine, caffeine, carnitine, forskolin and retinol, In vitro, ex vivo and in vivo studies. Int J Cosmetic Sci 2011;33:519-26.
8. Khan MH, Victor F, Rao B, et al. Treatment of cellulite: Part II. Advances and controversies. J Am Acad Dermatol 2010;62:373-84.
9. Al-Bader T, Byrne A, Gillbro J, et al. Effect of cosmetic ingredients as anticellulite agents: synergistic action of actives with in vitro and in vivo efficacy. J Cosmet Dermatol 2012;11:17-26.
10. Lesser T, Ritvo E, Moy LS. Modification of subcutaneous adipose tissue by a methylxanthine formulation: a double-blind controlled study. Dermatol Surg 1999;25:455-62.
11. Bertin C, Zunino H, Pittet J-C, et al. A double-blind evaluation of the activity of an anti-cellulite product containing retinol, caffeine, and ruscogenine by a combination of several non-invasive methods. J Cosmet Sci 2001;52:199-210.
12. Bolzinger M-A, Briançon S, Pelletier J, et al. Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms. Eur J Pharm Biopharm 2008;68:446-51.
13. Kim C, Shim J, Han S, et al. The skin-permeation-enhancing effect of phosphatidylcholine: caffeine as a model active ingredient. J Cosmet Sci 2002;53:363-74.
14. Rubio L, Alonso C, López O, et al. Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid. Int J Dermatol 2011;50:881-9.
15. Elias P, Feingold K. Stratum corneum barrier function: definitions and broad concepts. In: Elias P, Feingold K, eds. Skin barrier. New York (NY): Taylor & Francis; 2006:1-4.
16. Hexsel D, Orlandi C, Zechmeister do Prado D. Botanical extracts used in the treatment of cellulite. Dermatol Surg 2005;31:866-73.
17. Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther 2004;17:6-15.
18. Mei Z, Chen H, Weng T, et al. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003;56:189-96.
19. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366:170-84.
20. Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Del Rev 2001;47:165-96.
21. Wissing SA, Müller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm 2003;254:65-8.
22. Lopes LB, Ferreira DA, de Paula D, et al. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Pharm Res 2006;23:1332-42.
23. Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007;328:191-5.
24. Munster U, Nakamura C, Haberland A, et al. RU 58841-myristate prodrug development for topical treatment of acne and androgenetic alopecia. Die Pharmazie 2005;60:8-12.
25. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77.
26. Iannuccelli V, Sala N, Tursilli R, et al. Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability. Eur J Pharm Biopharm 2006;63:140-5.
27. Shah KA, Date AA, Joshi MD, et al. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2007;345:163-71.
28. Müller R, Radtke M, Wissing S. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Del Rev 2002;54:S131-55.
29. Müller RH, Lucks J. Inventors; Arzneistofftrager aus festen lipidteilchen, feste lipidnanospharen (SLN), patent EP0605497A1, 1996.
30. Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. Google Patents; 1993.
31. Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Controlled Release 2006;110:296-306.
32. Mezzena M, Scalia S, Young P, et al. Solid lipid budesonide microparticles for controlled release inhalation therapy. AAPS J 2009;11:771-8.
33. Elias PM. Stratum corneum defensive functions: an integrated view. J Gen Intern Med 2005;20:183-200.
34. Sinico C, Fadda A. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009;6:813-25.
35. Mihranyan A, Ferraz N, Strømme M. Current status and future prospects of nanotechnology in cosmetics. Prog Mater Sci 2012;57:875-910.
36. Rossi AM, Katz BE. A modern approach to the treatment of cellulite. Dermatol Clin 2014;32:51-9.